Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia

Gynecologic Oncology

Volumn 106, Issue 3, 2007, Pages 579-584

  Le, Tien ^a   Menard, Chantal ^a   Hicks Boucher, Wendy ^a   Hopkins, Laura ^a   Weberpals, Johanne ^a   Fung Kee Fung, Michael ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Imiquimod; Topical treatment; Vulvar intraepithelial neoplasia

Indexed keywords

IMIQUIMOD;

ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; ARTICLE; BURNING SENSATION; CANCER GROWTH; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG TOLERANCE; EROSION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER SURGERY; METHODOLOGY; MYALGIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; SKIN EXCORIATION; SKIN INDURATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE; VULVA TUMOR;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; FEMALE; HUMANS; MIDDLE AGED; VULVAR NEOPLASMS;

EID: 34548137811     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.019     Document Type: Article

References (36)

1. Herod J.J., Shafi M.I., Rollason T.P., Jordan J.A., and Luesley D.M. Vulva intraepithelial neoplasia with superficially invasive carcinoma of the vulva. Br. J. Obstet. Gynaecol. 103 (1996) 453-456
2. Jones R.W., Baranyai J., and Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulva intraepithelial neoplasia. Obstet. Gynecol. 90 (1997) 448-452
3. Al-Ghamdi A., Freedman D., Miller D., et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol. Oncol. 84 (2002) 94-101
4. Judson P.L., Habermann E.B., Baxter N.N., et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet. Gynecol. 107 (2006) 1018-1022
5. Van Seters M., Van Beurden M., and De Craen A.J.M. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol. Oncol. 97 2 (2005) 645-651
6. Likes W.M., Stegbauer C., Hathaway D., Brown C., and Tillmanns T. Use of the female sexual function index in women with vulvar intraepithelial neoplasia. J. Sex Marital Ther. 32 3 (2006) 255-266
7. Tillmanns T.D., Likes W., Pruett J., et al. Vulvar dysplasia: relationship of disease and treatment to the sense of sexuality-abstracts presented for the 34th annual meeting of the western association of gynecologic oncologists. Gynecol. Oncol. 100 1 (2006) 640
8. Likes W.M., Stegbauer C., Tillmanns T., and Pruett J. Correlates of sexual function following vulvar excision. Gynecol. Oncol. (2007) 10.1016/j.ygyno.2007.01.027 (electronic publication)
9. Disaia P.J., and Rich W.M. Surgical approach to multifocal carcinoma in situ of the vulva. Am. J. Obstet. Gynecol. 140 (1981) 136-145
10. Forney J.P., Morrow C.P., and Townsend D.E. Management of carcinoma in situ of the vulva. Am. J. Obstet. Gynecol. 127 8 (1977) 801-806
11. Buscema J., Naghashfar Z., Sawada E., Daniel R., Woodruff J.D., and Shah K. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet. Gynecol. 71 (1988) 601-606
12. Ikenberg H., Gissmann L., Gross G., Grussendorf-Conen E.I., et al. Human papillomavirus type-16-related DNA in genital Bowen's disease and in bowenoid papulosis. Int. J. Cancer 32 (1983) 563-565
13. Hampl M., Sarajuuri H., Wentzensen N., et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet. Gynecol. 108 (2006) 1361-1368
14. Srodon M., Stoler M.H., Baber G.B., et al. The distribution of low and high risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am. J. Surg. Pathol. 30 (2006) 1513-1518
15. Ho G.Y., Burk R.D., Fleming I., and Klein R.S. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int. J. Cancer 56 6 (1994) 788-792
16. Edwards L., Ferenczy A., and Eron L. Self administered topical 5% Imiquimod cream for external anogenital warts. Arch. Dermatol. 134 (1998) 25-30
17. Stanley M. Mechanism of action of Imiquimod. Papillomavirus Rep. 10 2 (1999) 23-29
18. Le T., Hicks W., Menard C., Hopkins L., and Fung Kee Fung M. Preliminary results of 5% Imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3. Am. J. Obstet. Gynecol. 194 2 (2006) 377-380
19. Hart W.R. Vulvar intraepithelial neoplasia: historical aspects and current status. Int. J. Gynecol. Pathol. 20 1 (2001) 16-30
20. Sideri M., Jones R.W., Wilkinson E.J., et al. Squamous vulvar intraepithelial neoplasia: 2004 Modified Terminology, ISVVD vulvar Oncology Subcommittee. J. Reprod. Med. 50 (2005) 807-810
21. Herod J., Shafi J.O., Rollason M.I., et al. Vulvar intraepithelial neoplasia; long-term follow-up of treated and untreated women. Obstet. Gynecol. Surv. 51 10 (1996) 597-599
22. Jones R.W., Rowan D.M., and Stewart A.W. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet. Gynecol. 106 6 (2005) 1319-1326
23. Geisse J., Caro I., Lindholm J., Golitz L., et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J. Am. Acad. Dermatol. 50 5 (2004) 722-733
24. Todd R.W., Steele J.C., Etherington I., and Luesley D.M. Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using Imiquimod as a treatment for high-grade vulval intraepithelial neoplasia. Gynecol. Oncol. 92 (2004) 167-174
25. Todd R.W., Etherington I.J., and Luesley D.M. The effects of 5% Imiquimod cream on high grade vulval intraepithelial neoplasia. Gynecol. Oncol. 85 (2002) 67-70
26. Wendling J., Saiag P., Berville-Levy S., et al. Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% Imiquimod cream. Arch. Dermatol. 140 (2004) 1220-1224
27. Fleischmann M., Celerier P., Bernard P., Litoux P., and Dreno B. Long term interferon alpha therapy induces autoantibodies against epidermis. Dermatology 192 1 (1996) 50-55
28. Campagne G., Roca M., and Martinez A. Successful treatment of a high-grade intra epithelial neoplasia with Imiquimod, with vulvar pemphigus as a side effect. Eur. J. Obstet. Gynaecol. Reprod. Biol. 109 (2003) 224-227
29. Davis G., Wentworth J., and Richard J. Self-administered topical Imiquimod treatment of vulvar intraepithelial neoplasia: a report of four cases. J. Reprod. Med. 45 (2000) 619-623
30. Diaz-Arrastia C., Arany I., Robazetti S.C., et al. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical Imiquimod 5%. Clin. Cancer Res. 7 (2001) 3031-3033
31. Travis L., Weinberg J., and Krumholz B. Successful treatment of vulvar intraepithelial neoplasia with topical Imiquimod 5% cream in a lung transplant patient. Acta Derm.-Venereol. (Oslo) 82 (2002) 475-476
32. Todd R.W., Etherington I.J., and Luesley D.M. The effects of 5% Imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecol. Oncol. 85 (2001) 67-70
33. Wendling J., Saiag P., Berville-Levy S., et al. Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% Imiquimod cream: a prospective study of 12 cases. Arch. Dermatol. 140 (2004) 1220-1224
34. van Seters M., Fons G., and van Beurden M. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study. J. Reprod. Med. 47 (2002) 701-705
35. Petrow W., Gerdsen R., Uerlich M., Richter O., and Bieber T. Successful topical immunotherapy of bowenoid papulosis with Imiquimod. Br. J. Dermatol. 145 (2001) 1022-1023
36. Jayne C.J., and Kaufman R.H. Treatment of vulva intraepithelial neoplasia 2/3 with Imiquimod. J. Reprod. Med. 47 (2002) 395-398